









Markets
/
Stocks
/
nasdaq-life
/

aTyr Pharma Ord Shs

LIFE

15.080

-1.770-10.50%

Close 01/30, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



aTyr Pharma Ord Shs

15.080

-1.770-10.50%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of aTyr Pharma Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--90.20M

- Cash and cash equivalents

--6.15M

-Short-term investments

--84.05M

Receivables

--1.04M

-Other receivables

--1.04M

Prepaid expenses

--1.77M

Total current assets

--93.01M

Non-current assets

Net Fixed Assets

--10.78M

Other non-current assets

--2.86M

Total non-current assets

--13.64M

Total assets

--106.65M

Liabilities

Current liabilities

Accrued expenses

--10.19M

Short-term debt and lease liabilities

--630.00K

-Short-term lease liabilities

--630.00K

Total current liabilities

--15.68M

Non-current liabilities

Long-term debt and lease liabilities

--10.53M

-Long-term lease liabilities

--10.53M

Total non-current liabilities

--10.93M

Total liabilities

--26.61M

Shareholders' equity

Common equity

--672.44M

Retained earnings

---592.20M

Capital reserves

--672.34M

Gains losses not affecting retained earnings

---1.00K

Non-controlling interests

---191.00K

Total equity

--80.04M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

